186 related articles for article (PubMed ID: 18266608)
21. Infection of Mosquito Cells (C6/36) by Dengue-2 Virus Interferes with Subsequent Infection by Yellow Fever Virus.
Abrao EP; da Fonseca BA
Vector Borne Zoonotic Dis; 2016 Feb; 16(2):124-30. PubMed ID: 26808727
[TBL] [Abstract][Full Text] [Related]
22. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
[TBL] [Abstract][Full Text] [Related]
23. Engineered resistance in Aedes aegypti to a West African and a South American strain of yellow fever virus.
Higgs S; Rayner JO; Olson KE; Davis BS; Beaty BJ; Blair CD
Am J Trop Med Hyg; 1998 May; 58(5):663-70. PubMed ID: 9598458
[TBL] [Abstract][Full Text] [Related]
24. Vector competence in West African Aedes aegypti Is Flavivirus species and genotype dependent.
Dickson LB; Sanchez-Vargas I; Sylla M; Fleming K; Black WC
PLoS Negl Trop Dis; 2014 Oct; 8(10):e3153. PubMed ID: 25275366
[TBL] [Abstract][Full Text] [Related]
25. Characterization of an infectious clone of the wild-type yellow fever virus Asibi strain that is able to infect and disseminate in mosquitoes.
McElroy KL; Tsetsarkin KA; Vanlandingham DL; Higgs S
J Gen Virol; 2005 Jun; 86(Pt 6):1747-1751. PubMed ID: 15914853
[TBL] [Abstract][Full Text] [Related]
26. Bicluster pattern of codon context usages between flavivirus and vector mosquito Aedes aegypti: relevance to infection and transcriptional response of mosquito genes.
Behura SK; Severson DW
Mol Genet Genomics; 2014 Oct; 289(5):885-94. PubMed ID: 24838953
[TBL] [Abstract][Full Text] [Related]
27. Absence of transmission of vYF next generation Yellow Fever vaccine in mosquitoes.
Bellone R; Mousson L; Bohers C; Mantel N; Failloux AB
PLoS Negl Trop Dis; 2022 Dec; 16(12):e0010930. PubMed ID: 36516120
[TBL] [Abstract][Full Text] [Related]
28. Infectivity of West Nile/dengue chimeric viruses for West Nile and dengue mosquito vectors.
Hanley KA; Goddard LB; Gilmore LE; Scott TW; Speicher J; Murphy BR; Pletnev AG
Vector Borne Zoonotic Dis; 2005; 5(1):1-10. PubMed ID: 15815144
[TBL] [Abstract][Full Text] [Related]
29. Is a dose of 17D vaccine in the current context of Yellow Fever enough?
Estofolete CF; Nogueira ML
Braz J Microbiol; 2018; 49(3):683-684. PubMed ID: 29588199
[No Abstract] [Full Text] [Related]
30. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
[TBL] [Abstract][Full Text] [Related]
31. A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes.
Troyer JM; Hanley KA; Whitehead SS; Strickman D; Karron RA; Durbin AP; Murphy BR
Am J Trop Med Hyg; 2001 Nov; 65(5):414-9. PubMed ID: 11716092
[TBL] [Abstract][Full Text] [Related]
32. Aedes (Stegomyia) aegypti in the continental United States: a vector at the cool margin of its geographic range.
Eisen L; Moore CG
J Med Entomol; 2013 May; 50(3):467-78. PubMed ID: 23802440
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the live attenuated yellow fever vaccine 17D-204 strain to its virulent parental strain Asibi by deep sequencing.
Beck A; Tesh RB; Wood TG; Widen SG; Ryman KD; Barrett AD
J Infect Dis; 2014 Feb; 209(3):334-44. PubMed ID: 24141982
[TBL] [Abstract][Full Text] [Related]
34. Aedes aegypti in Brazil: genetically differentiated populations with high susceptibility to dengue and yellow fever viruses.
Lourenço-de-Oliveira R; Vazeille M; de Filippis AM; Failloux AB
Trans R Soc Trop Med Hyg; 2004 Jan; 98(1):43-54. PubMed ID: 14702837
[TBL] [Abstract][Full Text] [Related]
35. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
[TBL] [Abstract][Full Text] [Related]
36. Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys.
Trindade GF; Marchevsky RS; Fillipis AM; Nogueira RM; Bonaldo MC; Acero PC; Caride E; Freire MS; Galler R
An Acad Bras Cienc; 2008 Jun; 80(2):311-21. PubMed ID: 18506257
[TBL] [Abstract][Full Text] [Related]
37. Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.
Liang H; Lee M; Jin X
Cell Mol Immunol; 2016 Jan; 13(1):36-46. PubMed ID: 26435066
[TBL] [Abstract][Full Text] [Related]
38. Comparative Infections of Zika, Dengue, and Yellow Fever Viruses in Human Cytotrophoblast-Derived Cells Suggest a Gating Role for the Cytotrophoblast in Zika Virus Placental Invasion.
Viettri M; Caraballo G; Sanchez ME; Espejel-Nuñez A; Betanzos A; Ortiz-Navarrete V; Estrada-Gutierrez G; Nava P; Ludert JE
Microbiol Spectr; 2023 Jun; 11(3):e0063023. PubMed ID: 37227282
[TBL] [Abstract][Full Text] [Related]
39. Limited Transmission Potential of Takeda's Tetravalent Dengue Vaccine Candidate by
Dietrich EA; Ong YT; Stovall JL; Dean H; Huang CY
Am J Trop Med Hyg; 2017 Nov; 97(5):1423-1427. PubMed ID: 28820715
[TBL] [Abstract][Full Text] [Related]
40. The occurrence, diversity and blood feeding patterns of potential vectors of dengue and yellow fever in Kacheliba, West Pokot County, Kenya.
Chepkorir E; Venter M; Lutomiah J; Mulwa F; Arum S; Tchouassi DP; Sang R
Acta Trop; 2018 Oct; 186():50-57. PubMed ID: 30006028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
